Home
About
Pricing
Log In
Back
MEU
Asset Logo

Marmota Limited

🇦🇺 ASX

⚡️ ENERGY

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

+ 6.80%
Annual Growth

5 years average annual capital growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

8
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Marmota Ltd. engages in exploring mineral activities. The company is headquartered in Adelaide, South Australia. The company went IPO on 2007-11-21. The firm is focused on gold, copper and uranium. The firm's projects include Gawler Craton, Copper Coast, Yorke Peninsula and Junction Dam. The Company’s copper project is based at the Melton project on the Yorke Peninsula. The firm's uranium project is at Junction Dam adjacent to the Honeymoon mine. The Gawler Craton gold project comprises around 6,000 square kilometers in the Woomera Prohibited Area. The company has been active on the Champion Prospect in the West Melton tenement (100% owned), on the Copper Coast of the Yorke Peninsula. Junction Dam is the Company’s flagship uranium project, located 50 kilometers (km) west of Broken Hill.

📈 Performance

Price History

+318.75%

1M

1Y

10Y

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.07

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in MEU

8

📊 Total Capital Earnings

$10K

🔃 Average investment frequency

35 weeks

💵 Average investment amount

$2,230

Last time a customer invested in MEU

6 days
MEU investor breakdown
💵 Income of investors

More than 200k

10%

150k - 200k

10%

100k - 150k

40%

50k - 100k

10%

Less than 50k

20%
👶 Age of investors

18 - 25

26 - 34

38%

35 - 90

63%
🙋 Legal gender of investors

Female

38%

Male

63%

Pearlers who invest in MEU also invest in...

Vanguard Australian Shares Index ETF

VAS

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

🙌 Performance (5Yr p.a)

8.42%

📊 Share price

$111.98 AUD

🇦🇺 AUSTRALIA

💸 FINANCIALS

⛳️ DIVERSIFIED

📈 HIGH PRICE GROWTH

🧱 MATERIALS

Find Out More

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

🙌 Performance (5Yr p.a)

7.76%

📊 Share price

$74.87 AUD

🌏 GLOBAL

⛳️ DIVERSIFIED

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. The company is headquartered in Melbourne, Victoria. The company went IPO on 2004-12-16. The company has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad portfolio of late-stage product candidates. The company is developing product candidates for distinct indications based on its remestemcel-L and rexlemestrocel-L allogeneic stromal cell technology platforms. Remestemcel-L is being developed for inflammatory diseases in children and adults including steroid refractory acute graft versus host disease, and biologic-resistant inflammatory bowel disease. Rexlemestrocel-L is being developed for advanced chronic heart failure (REVASCOR) and chronic low back pain (MPC-06-ID). Two products have been commercialized in Japan and Europe by the Company's licensees. The company has established commercial partnerships in Europe and China for certain Phase III assets.

🙌 Performance (5Yr p.a)

-3.07%

📊 Share price

$2.70 AUD

🧬 BIOTECHNOLOGY

🕊️ SOCIALLY AWARE

Goodman Group operates as a provider of essential infrastructure. The company is headquartered in Rosebery, New South Wales and currently employs 1,030 full-time employees. The company went IPO on 2005-02-02. The firm owns, develops and manages high-quality, sustainable logistics properties and data centers in major global cities that are critical to the digital economy. Its operating segments are Australia and New Zealand, Asia (Greater China (including the Hong Kong SAR) and Japan), Continental Europe (with assets located in Germany, France, Spain and the Netherlands), the United Kingdom and the Americas (principally North America and including Brazil). The firm comprises the stapled entities Goodman Limited, Goodman Industrial Trust and Goodman Logistics (HK) Limited. Its property portfolio includes logistics and distribution centers, warehouses, light industrial, multi-story industrial, business parks and data centers. The company takes a long-term view, investing significantly alongside its capital partners in its investment management platform and concentrating on the portfolio where it can create value for customers and investors.

🙌 Performance (5Yr p.a)

16.58%

📊 Share price

$33.76 AUD

📈 HIGH PRICE GROWTH

🏠 REAL ESTATE

Lynas Rare Earths Ltd. engages in the production of rare earth minerals. The company is headquartered in Perth, Western Australia and currently employs 1,127 full-time employees. The Company’s operations include Mt Weld, Lynas Malaysia, Kalgoorlie and Lynas USA. The company focuses on developing the Mt Weld resource, which includes ongoing exploration, production of mixed rare earths concentrates, and an expansion project to increase concentrate feedstock production to support 12,000 tons per annum of finished NdPr oxide. The Lynas Malaysia advanced materials plant is located on a 100-hectare site in the Gebeng Industrial Estate, a purpose-built petrochemical industry zone near Kuantan, on the east coast of Malaysia. Its rare earths processing facility in Kalgoorlie undertakes value-added processing of rare earths. The firm's subsidiaries include Lynas Malaysia Sdn Bhd, Lynas Africa Ltd, Lynas Kalgoorlie Pty Ltd and Lynas USA LLC.

🙌 Performance (5Yr p.a)

105.98%

📊 Share price

$18.33 AUD

🕊️ SOCIALLY AWARE

⛏️ MINING

Want more shares? Try these...

Compare
Add to watchlist